Clinical Trial Update: Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sequential chemotherapy CLAGE-Ven with reduced-intensity conditioning for refractory acute myeloid leukemia; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CLAGE-Ven
• Venclexta (venetoclax)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Refractory Leukemia | Phase 2 | Status: RECRUITING